Every 8-K that Microbot Medical, Inc. (MBOT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow MBOT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MBOT filings page.
Microbot Medical Inc. reported that the U.S. Patent and Trademark Office has granted it a patent covering a modular robotic surgical system with a base and multiple independently attachable tool-receiver units. The company explains that this patent may allow its LIBERTY device to be adapted over time for a wider range of endovascular procedures, which could substantially increase the total addressable market it seeks to reach. The patent also broadens Microbot’s intellectual property protection for the LIBERTY system portfolio, which now consists of 12 patents granted globally and 57 patent applications pending.